Synthetic lethality: Targeting DNA repair mechanisms in clinical trials

被引：0
|
作者：
Tutt, Andrew [1 ]
机构：
[1] Kings Hlth Partners AHSC, Guys Hosp, Integrated Canc Ctr, London, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-PL04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL04-02
引用
收藏
页数：1
相关论文
共 50 条
  • [41] DNA repair mechanisms and their clinical impact in glioblastoma
    Erasimus, Helene
    Gobin, Matthieu
    Niclou, Simone
    Van Dyck, Eric
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 19 - 35
  • [42] DNA Repair: from mechanisms to clinical application
    Mansour, W.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S230 - S230
  • [43] Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
    Kwok, Marwan
    Davies, Nicholas
    Agathanggelou, Angelo
    Smith, Edward
    Petermann, Eva
    Yates, Eliot
    Brown, Jeffrey
    Lau, Alan
    Stankovic, Tatjana
    LANCET, 2015, 385 : 58 - 58
  • [44] The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic
    Ivy, S. Percy
    de Bono, Johann
    Kohn, Elise C.
    TRENDS IN CANCER, 2016, 2 (11): : 646 - 656
  • [45] Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics
    Bhattacharjee, Sonali
    Nandi, Saikat
    IUBMB LIFE, 2017, 69 (12) : 929 - 937
  • [46] Targeting epigenetics using synthetic lethality in precision medicine
    Chen, Ee Sin
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (18) : 3381 - 3392
  • [47] Targeting epigenetics using synthetic lethality in precision medicine
    Ee Sin Chen
    Cellular and Molecular Life Sciences, 2018, 75 : 3381 - 3392
  • [48] Targeting synthetic lethality with PARP inhibition in colorectal cancer
    Augustine, Titto
    Maitra, Radhashree
    Zhang, Jinghang
    Nayak, Jay
    Goel, Sanjay
    CANCER RESEARCH, 2016, 76
  • [49] Targeting DNA Repair and Defective DNA repair
    de Bono, Johann
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [50] Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
    He, Yundong
    Xu, Weidong
    Xiao, Yu-Tian
    Huang, Haojie
    Gu, Di
    Ren, Shancheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
12345